tiprankstipranks
Kilitch Drugs (India) Limited (IN:KILITCH)
:KILITCH
India Market
KILITCH
Kilitch Drugs (India) Limited
RESEARCH TOOLSreports

Kilitch Drugs (India) Limited (KILITCH) Income Statement

0 Followers

Kilitch Drugs (India) Limited Income Statement

Last quarter (Q2 2026), Kilitch Drugs (India) Limited's total revenue was ₹489.25M, an increase of 3.05% from the same quarter last year. In Q2, Kilitch Drugs (India) Limited's net income was ₹81.90M. See Kilitch Drugs (India) Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 1.98B₹ 1.54B₹ 1.40B₹ 1.14B₹ 681.28M
Gross Profit
₹ 937.39M₹ 731.38M₹ 624.64M₹ 337.44M₹ 300.07M
Operating Expenses
₹ 653.84M₹ 520.28M₹ 473.73M₹ 247.27M₹ 152.44M
Depreciation and Amortization
₹ 31.10M₹ 33.50M₹ 35.51M₹ 24.66M₹ 19.86M
EBITDA
₹ 426.26M₹ 287.43M₹ 206.50M₹ 134.13M₹ 79.85M
Operating Income
₹ 283.55M₹ 211.11M₹ 148.60M₹ 89.85M₹ 36.19M
Other Income/Expenses
₹ 61.19M₹ -17.56M₹ -28.45M₹ 6.29M₹ 15.01M
Pretax Income
₹ 344.74M₹ 193.54M₹ 120.14M₹ 96.14M₹ 51.20M
Net Income
₹ 267.01M₹ 146.01M₹ 104.48M₹ 73.67M₹ 36.71M
Per Share Metrics
Basic EPS
₹ 8.12₹ 4.49₹ 3.29₹ 2.31₹ 1.19
Diluted EPS
₹ 8.12₹ 4.49₹ 3.29₹ 2.31₹ 1.19
Weighted Average Shares Outstanding
 32.17M 31.85M 31.16M 31.13M 30.98M
Weighted Average Shares Outstanding (Diluted)
 32.17M 31.85M 31.16M 31.13M 30.96M
Currency in INR

Kilitch Drugs (India) Limited Earnings and Revenue History